ARCHIVES

Toxicology Program Board To Review Nine Substances.

This article is from The Cancer Letter archive.

Vol. 26 No. 02 | January 14, 2000

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986